In this episode of The Scalpel’s Edge, Dr. Tim Sayed reviews a newly published study from Colombia examining outcomes in women with breast implant illness following explant surgery. With over 125 patients and 18 months of follow-up, this research reveals significant improvements in symptoms such as joint pain, fatigue, and hair loss — and offers valuable insight into the science, skepticism, and evolving understanding of BII. Dr. Sayed breaks down the data, discusses parallels with U.S. studi...
All content for The Scalpel's Edge is the property of Dr. Tim Sayed and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of The Scalpel’s Edge, Dr. Tim Sayed reviews a newly published study from Colombia examining outcomes in women with breast implant illness following explant surgery. With over 125 patients and 18 months of follow-up, this research reveals significant improvements in symptoms such as joint pain, fatigue, and hair loss — and offers valuable insight into the science, skepticism, and evolving understanding of BII. Dr. Sayed breaks down the data, discusses parallels with U.S. studi...
Ep. 19 - FDA Warnings, Compounded GLP1s, and the Next Generation of Weight Loss Medications
The Scalpel's Edge
28 minutes
1 month ago
Ep. 19 - FDA Warnings, Compounded GLP1s, and the Next Generation of Weight Loss Medications
In this episode of The Scalpel’s Edge, Dr. Tim Sayed takes a deep dive into the shifting regulatory landscape for compounded GLP1 medications and what recent FDA warning letters mean for providers, pharmacies, and patients. He also reviews promising new clinical trial data on Pfizer’s experimental drug MET97, which may offer greater weight loss with fewer side effects compared to current options. From the nuances of verbiage in compounding claims to the future of monthly dosing and oral formu...
The Scalpel's Edge
In this episode of The Scalpel’s Edge, Dr. Tim Sayed reviews a newly published study from Colombia examining outcomes in women with breast implant illness following explant surgery. With over 125 patients and 18 months of follow-up, this research reveals significant improvements in symptoms such as joint pain, fatigue, and hair loss — and offers valuable insight into the science, skepticism, and evolving understanding of BII. Dr. Sayed breaks down the data, discusses parallels with U.S. studi...
